L3 Effectiveness of Influenza Vaccines Against Pandemic H1N1 Among Children

Thursday, March 31, 2011: 10:30 AM-11:30 AM
Presenters in this workshop will discuss the effectiveness of the 2009 H1N1 monovalent influenza vaccine. Various methods for evaluating the success of influenza vaccine programs will be explored.
Joseph Bresee

10:30 AM
Effectiveness of One Dose of 2009 Monovalent H1N1 Vaccine at Preventing Hospitalization with Pandemic H1N1 Influenza In Children 7 Months to 9 Years of Age, New York City
James Hadler, MD, MPH, Public Health Consultant, New York City Department of Health and Mental Hygiene; Tai Baker, MPH, CHES; Vikki Papadouka, PhD, MPH; Anne Marie France, PhD; Christopher M. Zimmerman, MD, MPH; Kara Livingston, MPH; Jane R. Zucker, MD, MSc
11:00 AM
Various Measures of the Effectiveness of 2009 H1N1 Influenza Vaccination Among Children Vaccinated at School During the 2009 Influenza Pandemic In Maine
Ricardo Basurto-Davila, PhD, MS, Prevention Effectiveness Fellow, Centers for Disease Control and Prevention; Mark Thompson, PhD; Nancy Dube, RN, MPH; Sandra Chaves, MD, MSc; Jill Ferdinands, PhD; Samuel Graitcer, MD; Lydia Foster, MS; Peter Smith, PhD; Amra Uzicanin, MD, MPH; Meredith Tipton, PhD, MPH; Jufu Chen, PhD; Paul Gargiullo, PhD; Rebel Jackson, RN, NCSN, MPA; Arnold Monto, MD, MPH; David Shay, MD, MPH
See more of: Submissions